Reported Reactions

Devices › Implant, dermal, for aesthetic use

Device brand name · Implant dermal for aesthetic use

UNK Dermal Filler: medical device reports filed with FDA

183 reports name it, 2014–2026. Product code LMH.

183
device reports naming the brand
0% of all MAUDE reports · about 15 a year
25
reports, 12 months to August 2026
19 in the 12 months before
1.6%
classified as malfunction
7.2% across the product code
0.5%
classified as death, as reported
1 reports · not verified by FDA

183 medical device reports received by FDA name the brand "UNK Dermal Filler" (implant dermal for aesthetic use); received from March 2014 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

25 reports arrived in the 12 months to August 2026, up 32% from 19 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (97.8%), malfunction (1.6%) and death (0.5%); across all implant, dermal, for aesthetic use reports (product code LMH) death is recorded in 0.1% and malfunction in 7.2%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are improper or incorrect procedure or method (18%), off-label use (1.6%) and migration (1.1%). The patient problems coded most often are obstruction/occlusion, nodule and abscess. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

047Sep 2021: 6Oct 2021: 1Nov 2021: 2Dec 2021: 22022Jan 2022: 2Feb 2022: 0Mar 2022: 2Apr 2022: 5May 2022: 1Jun 2022: 1Jul 2022: 1Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 12023Jan 2023: 1Feb 2023: 1Mar 2023: 4Apr 2023: 1May 2023: 2Jun 2023: 2Jul 2023: 2Aug 2023: 1Sep 2023: 2Oct 2023: 2Nov 2023: 2Dec 2023: 02024Jan 2024: 1Feb 2024: 2Mar 2024: 5Apr 2024: 3May 2024: 1Jun 2024: 3Jul 2024: 2Aug 2024: 0Sep 2024: 2Oct 2024: 0Nov 2024: 2Dec 2024: 22025Jan 2025: 1Feb 2025: 1Mar 2025: 1Apr 2025: 3May 2025: 2Jun 2025: 2Jul 2025: 3Aug 2025: 0Sep 2025: 1Oct 2025: 2Nov 2025: 3Dec 2025: 52026Jan 2026: 0Feb 2026: 0Mar 2026: 3Apr 2026: 1May 2026: 0Jun 2026: 1Jul 2026: 7Aug 2026: 2

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

016322014: 420142015: 52016: 720162017: 122018: 520182019: 152020: 920202021: 322022: 1320222023: 202024: 2320242025: 242026: 142026

Event type and report source

Event type, as classified on the report

Death0.5%1
Injury97.8%179
Malfunction1.6%3
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%183
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 22,802 reports carrying product code LMH. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Improper or incorrect procedure or method3318%7.5%
Off-label use31.6%4.2%
Migrationthe device moved from where it was placed21.1%0.4%
Device appears to trigger rejection10.5%0.2%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Obstruction/occlusion2815.3%
Nodule2714.8%
Abscessa collection of pus2111.5%
Inflammationinflammation147.7%
Necrosisdeath of tissue126.6%
Skin irritationirritated skin105.5%
Loss of vision84.4%
Edemaswelling from fluid63.3%
Cellulitisa skin infection52.7%
Osteolysis52.7%
Vascular system (circulation), impaired52.7%
Hypersensitivity/allergic reaction42.2%
Skin discoloration31.6%
Subcutaneous nodule31.6%
Foreign body embolism21.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureUNK Dermal FillerProduct code LMHAll MAUDE reports
Reports18322,80226,136,888
Share of that pool—0.8%0%
Classified as death, per 1,000 reports519
Classified as injury97.8%83.7%36.2%
Classified as malfunction1.6%7.2%62.3%
Filed by the manufacturer100%95.3%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code LMH

BrandReportsLatest 12 monthsClassified as death
Sculptra1,593910%
Juvederm Voluma Xc/Lido Volume Unknown1,0471940.1%
Juvederm Voluma XC 27G 2 x 1mL901780%
Juvederm Ultra Xc Tsk Us68110%
Unk Volbella663700%
VOLBELLA with LIDOCAINE64150.2%
Juvederm VOLUMA WITH LIDOCAINE 1mL622230%
Radiesse Dermal Filler59600%
Juvederm Volume/Concentration/Additive Unknown502240.6%
Juvederm Ultra Plus Xc Tsk Us49550%
Zyplast Collagen Implant46600%
VOLIFT with LIDOCAINE458100%
Unk Juvederm Volux4451330%
Radiesse Injectable Implant44100%
JUVEDERM VOLLURE XC 2x1 mL427240.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about UNK Dermal Filler reports

How many FDA reports name UNK Dermal Filler?

183 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 25 in the latest 12 months.

What kinds of events are reported?

injury (97.8%), malfunction (1.6%) and death (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

improper or incorrect procedure or method (18%), off-label use (1.6%), migration (1.1%) and device appears to trigger rejection (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that UNK Dermal Filler was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.